Cargando…
Use of patient-derived xenograft mouse models in cancer research and treatment
Autores principales: | Yada, Erica, Wada, Satoshi, Yoshida, Shintaro, Sasada, Tetsuro |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Future Science Ltd
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5859329/ https://www.ncbi.nlm.nih.gov/pubmed/29568561 http://dx.doi.org/10.4155/fsoa-2017-0136 |
Ejemplares similares
-
Identification of a novel HLA-A24-restricted cytotoxic T lymphocyte epitope peptide derived from mesothelin in pancreatic cancer
por: Tsukagoshi, Mariko, et al.
Publicado: (2018) -
Patient-Derived Xenograft Models in Cancer Research
por: van Weerden, Wytske M.
Publicado: (2021) -
Possible Role of Cytochrome P450 1B1 in the Mechanism of Gemcitabine Resistance in Pancreatic Cancer
por: Yada, Erica, et al.
Publicado: (2021) -
Patient-derived xenograft models—the future of personalised cancer treatment
por: Bhimani, Jenna, et al.
Publicado: (2020) -
The ongoing trends of patient‐derived xenograft models in oncology
por: Zhuo, Jianyong, et al.
Publicado: (2020)